Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Nuara

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Dermatitis : Contact, Atopic, Occupational, Drug|June 2, 2012
Recall dermatitis at patch test sites in alopecia areata treated with diphencyproneAnthony Nuara, Ponciano D Cruz
Journal of the American Academy of Dermatology|November 19, 2013
Papular xanthomas with destructive arthritisRachel Andrew, Anthony Nuara, Martha McCollough, et al.
Archives of Dermatology|July 20, 2011
Perifollicular papules and hyperkeratotic plaques on the back in a blaschkoid distribution. Morphea with features of lichen sclerosus et atrophicus (LS)Larissa Stewart, Anthony Nuara, Dipti Anand, et al.
Future Microbiology|July 31, 2007
Human monkeypox: an emerging zoonotic diseaseScott Parker, Anthony Nuara, R Mark L Buller, et al.
Diagnostic Microbiology and Infectious Disease|January 21, 2014
Mycobacterium leprae and Mycobacterium haemophilum co-infection in an iatrogenically immunosuppressed patientJeffrey A SoRelle, Stacy G Beal, David M Scollard, et al.
Dermatology and Therapy|October 22, 2025
Long-Term Integrated Safety Summary of Ruxolitinib Cream in Phase 3 Clinical Trials of Patients with VitiligoDavid Rosmarin, Amit G Pandya, Thierry Passeron, et al.
The British Journal of Dermatology|December 17, 2025
Open-label treatment extension of ruxolitinib cream in vitiligo: findings from the TRuE-V long-term extension phase 3 studyJohn E Harris, Kim Papp, Khaled Ezzedine, et al.
The British Journal of Dermatology|December 26, 2025
Randomized, double-blind treatment withdrawal or continuation with ruxolitinib cream in vitiligo: findings from the TRuE-V long-term extension phase 3 studyJohn E Harris, Kim Papp, Khaled Ezzedine, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Dermatitis : Contact, Atopic, Occupational, Drug|June 2, 2012
Recall dermatitis at patch test sites in alopecia areata treated with diphencyproneAnthony Nuara, Ponciano D Cruz
Journal of the American Academy of Dermatology|November 19, 2013
Papular xanthomas with destructive arthritisRachel Andrew, Anthony Nuara, Martha McCollough, et al.
Archives of Dermatology|July 20, 2011
Perifollicular papules and hyperkeratotic plaques on the back in a blaschkoid distribution. Morphea with features of lichen sclerosus et atrophicus (LS)Larissa Stewart, Anthony Nuara, Dipti Anand, et al.
Future Microbiology|July 31, 2007
Human monkeypox: an emerging zoonotic diseaseScott Parker, Anthony Nuara, R Mark L Buller, et al.
Diagnostic Microbiology and Infectious Disease|January 21, 2014
Mycobacterium leprae and Mycobacterium haemophilum co-infection in an iatrogenically immunosuppressed patientJeffrey A SoRelle, Stacy G Beal, David M Scollard, et al.
Dermatology and Therapy|October 22, 2025
Long-Term Integrated Safety Summary of Ruxolitinib Cream in Phase 3 Clinical Trials of Patients with VitiligoDavid Rosmarin, Amit G Pandya, Thierry Passeron, et al.
The British Journal of Dermatology|December 17, 2025
Open-label treatment extension of ruxolitinib cream in vitiligo: findings from the TRuE-V long-term extension phase 3 studyJohn E Harris, Kim Papp, Khaled Ezzedine, et al.
The British Journal of Dermatology|December 26, 2025
Randomized, double-blind treatment withdrawal or continuation with ruxolitinib cream in vitiligo: findings from the TRuE-V long-term extension phase 3 studyJohn E Harris, Kim Papp, Khaled Ezzedine, et al.
Pageof 1